Heidi Meredith, MD
Psychiatry · Skokie, ILNPI 1538191754
Payments from drug & device makers
Across 138 payments — averaging $18.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$461
- Otsuka America Pharmaceutical, Inc.$401
- Johnson & Johnson$384
- Lundbeck LLC$195
- Neurocrine Biosciences, Inc.$167
- Takeda Pharmaceuticals U.S.A., Inc.$147
- plus $834 from 19 others
What the payments were for
- Food & beverage$2,590100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 23 | $461 |
| Otsuka America Pharmaceutical, Inc. | 28 | $401 |
| Johnson & Johnson | 14 | $384 |
| Lundbeck LLC | 11 | $195 |
| Neurocrine Biosciences, Inc. | 8 | $167 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $147 |
| Alkermes, Inc. | 5 | $109 |
| Teva Pharmaceuticals USA, Inc. | 3 | $62 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $62 |
| Shire North American Group Inc | 4 | $61 |
| Tris Pharma Inc | 3 | $59 |
| Sunovion Pharmaceuticals Inc. | 3 | $55 |
| Bausch Health US, LLC | 3 | $51 |
| Novo Nordisk | 3 | $50 |
| OWP Pharmaceuticals, Inc. | 3 | $48 |
| Avanir Pharmaceuticals, Inc. | 3 | $45 |
| Ironshore Pharmaceuticals Inc. | 2 | $42 |
| Neos Therapeutics, LP | 2 | $37 |
| Corium, LLC | 1 | $33 |
| Harmony Biosciences LLC | 1 | $31 |
| Livanova USA, Inc. | 1 | $20 |
| Acadia Pharmaceuticals Inc | 1 | $20 |
| Alfasigma USA, Inc. | 1 | $18 |
| Vertical Pharmaceuticals, LLC | 1 | $18 |
| Adlon Therapeutics L.p. | 1 | $15 |
How this compares
$2,590 in reported general payments places this provider in the 80th percentile of 1,344 psychiatry providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EmsamSelegiline | 12 | $24,270 |
| Bupropion XlBupropion Hcl | 49 | $2,026 |
| Duloxetine Hcl | 45 | $1,174 |
| Aripiprazole | 12 | $932 |
| Mirtazapine | 11 | $572 |
| Methylphenidate Hcl | 14 | $465 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 12 | $306 |
| Paroxetine Hcl | 22 | $255 |
| Fluoxetine Hcl | 14 | $225 |
| Trazodone Hcl | 28 | $190 |
| Sertraline Hcl | 14 | $173 |
| Clonazepam | 35 | $166 |
| Citalopram HbrCitalopram Hydrobromide | 16 | $121 |
| Alprazolam | 22 | $110 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Skokie
- John ZajeckaSkokie$2.5M
- Mark ShukhmanSkokie$250K
- Jeffrey RossNorthbrook$10.8M
- Yuhwen ChowChicago$8.5M
- Mark LermanNorthbrook$4.5M
- Danesh AlamWinfield$2.7M
- Riaz BaberNaperville$2.4M
- Michael GreenbaumLibertyville$2.2M
- Sandeep GaonkarNaperville$1.8M
- Jon GrantChicago$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.